ALB and acute kidney injury: Seventeen trials involving 3917 patients were included: 11 studies (six with surgical or intensive care unit patients and 5 patients from other hospital departments) enabled assessment of the influence of serum albumin on the AKI incidence and 6 studies enabled the relationship between lowering of the serum albumin levels and mortality in patients who had developed AKI.